Status:
COMPLETED
Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients
Lead Sponsor:
Nordsjaellands Hospital
Conditions:
Diabetes
Covid-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial of isolated patients with diabetes admitted to Nordsjællands Hospital with or without COVID-19-pneumonia. A continuous glucose monitoring (CGM) based system with ...
Detailed Description
Epidemics and pandemics are a constant threat to health care systems globally. This stresses the importance of preparedness for a large amount of hospitalized quarantined patients in isolation, with t...
Eligibility Criteria
Inclusion
- Hospitalized with confirmed COVID-19 infection by real-time PCR or another validated method OR hospitalized with a non-COVID-19 diagnosis AND in isolation at time of inclusion.
- A documented clinically relevant history of diabetes or newly discovered during hospitalization.
- Written informed consent obtained before any trial related procedures are performed.
- Male or female aged over 18 years of age.
- Must be able to communicate with the study personnel.
- The subject must be willing and able to comply with trial protocol.
Exclusion
- 1\. Known hypersensitivity to the band-aid of the Dexcom G6 sensors
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04430608
Start Date
May 25 2020
End Date
April 25 2021
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nordsjællands Hospital
Hillerød, Denmark, 3400